Logo image
 Open Research University homepage
Surrey researchers Sign in
Back
The selective extrasynaptic GABA(A) agonist, gaboxadol, improves traditional hypnotic efficacy measures and enhances slow wave activity in a model of transient insomnia
Journal article   Peer reviewed

The selective extrasynaptic GABA(A) agonist, gaboxadol, improves traditional hypnotic efficacy measures and enhances slow wave activity in a model of transient insomnia

JK Walsh, S Deacon, D-J Dijk and J Lundahl
SLEEP, Vol.30(5), pp.593-602
01/05/2007

Abstract

Science & Technology Life Sciences & Biomedicine Clinical Neurology Neurosciences Neurosciences & Neurology CLINICAL NEUROLOGY NEUROSCIENCES gaboxadol slow wave sleep transient insomnia selective extrasynaptic GABA agonist phase advance SEGA HEALTHY ELDERLY SUBJECTS EEG SLEEP DATA PHARMACOLOGICAL CHARACTERIZATION PHASE ADVANCE POWER-DENSITY NREM SLEEP REM-SLEEP DEPRIVATION RECEPTORS ZOLPIDEM
url
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000246747800010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View
Author

Metrics

Details

Logo image

Usage Policy

Usage details for all content viewed and downloaded in this site are shared with IRUS-UK (Institutional Repository Usage Statistics UK). Cookies are used to remember your decision. Click Accept to accept usage details sharing and the cookies.

Learn more